Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.2500 (-3.34%) ($22.2500 - $22.2500) on Mon. Jul. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.47% (three month average) | RSI | 32 | Latest Price | $22.2500(-3.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(41%) ARKG(40%) IWO(40%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -3.235% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) TBT(-5%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.235% (StdDev 6.47%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $24.55 | 5 Day Moving Average | $23.23(-4.22%) | 10 Day Moving Average | $23.2(-4.09%) | 20 Day Moving Average | $24.55(-9.37%) | To recent high | -32.6% | To recent low | 37.7% | Market Cap | $3.258b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |